- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about Multiple sclerosis
Recent news which mentions Multiple sclerosis
From Benzinga
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
December 21, 2023
Tickers
HUGE
From Benzinga
From PRLog
Promising Multiple Sclerosis Drug Candidate Advances: First Clinical Trial Dosing Completed
May 10, 2023
Tickers
HUGE
From Benzinga
How to help loved ones with disabilities during the holidays, from a TV host whose family struggled with aunt's MS diagnosis
December 20, 2022
From CNBC.com News
Michelle Obama's new book puts a spotlight on multiple sclerosis and her father's late diagnosis: Here are 5 early signs of the disease
November 16, 2022
From CNBC.com News
EXCLUSIVE: Pasithea's Multiple Sclerosis Vaccine Candidate Shows Efficacy In Animal Studies, With Potential In Monkeypox
August 11, 2022
Tickers
KTTA
From Benzinga
Biogen Reveals $900M Settlement In Whistleblower's MS Drug Kickbacks Lawsuit Days Before Trial
July 21, 2022
From Benzinga
DEA Sued By Rhode Island Lab Over 'Foot Dragging' On Marijuana Pharmaceutical Licensing, Here's What We Know For Now
April 13, 2022
From Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
April 05, 2022
Tickers
NVS
From Benzinga
Tickers
BMY
Michigan's JARS Cannabis And Others Join Forces To Raise Awareness During MS Awareness Month
March 21, 2022
Tickers
RSO
From Benzinga
EXCLUSIVE: Pasithea Therapeutics Starts New Multiple Sclerosis Vaccine Development Program
February 03, 2022
Tickers
KTTA
From Benzinga
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
November 30, 2021
From Benzinga
5 Things You Might Not Know About Apple CEO Tim Cook
October 29, 2021
From Benzinga
From Benzinga
Clene's Stock Gain As Its Nanotherapeutic Improves Energy Production, Brain Utilization In Patients With Parkinson's, Multiple Sclerosis
August 05, 2021
Tickers
CLNN
From Benzinga
Tickers
TC
From TechCrunch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.